| Prostate Cancer Dietary factors - Glycemic Factors/Inflammatory Factors |
Ann Hsing |
NCI, DCEG, HREB |
PLCO |
Jul 1, 2006 |
2006-0147 |
| Prostate Cancer Dietary Factors - Meat Related Mutagens (Heterocyclic amines in meat cooked at high temperature and prostate cancer ) |
Amanda Cross |
NCI, DCEG, NEB |
PLCO |
Jul 1, 2006 |
2006-0066 |
| Prostate Cancer, Insulin Resistance and Obesity: Biochemistry and Genetics |
Ann Hsing |
NCI, DCEG, HREB |
PLCO |
Jul 1, 2006 |
2006-0146 |
| Prostate Cancer Other Factors-Family History |
Juan Alguacil |
NCI, DCEG, OEEB |
PLCO |
Jul 1, 2006 |
2006-0026 |
| Prostate Cancer Other Factors-NSAIDs |
Ann Hsing |
NCI, DCEG, HREB |
PLCO |
Jul 1, 2006 |
2006-0223 |
| Prostate cancer risk in relation to obesity and diabetes: A pooled analysis (Cohort Consortium Study) |
Ann Hsing |
NCI, DCEG, HREB |
PLCO |
Mar 25, 2011 |
2011-0053 |
| Prostate cancer risk prediction using clinical risk factors and genetics |
Nathan White |
Multimodal Imaging Services Corporation, dba HealthLytix |
PLCO |
Jan 30, 2020 |
PLCO-574 |
| Prostate Cancer Screening using Machine Learning |
Jerry John Rawlings Mensah |
Virginia Commonwealth University |
PLCO |
Nov 5, 2024 |
PLCO-1732 |
| Prostate Cancer Survival in PLCO: The effect of screening |
Paul Pinsky |
NCI, DCP, EDRG |
PLCO |
Mar 3, 2011 |
2010-0301 |
| Prostate cancer treatment choices in PLCO |
Robert Grubb |
Washington University School of Medicine in St. Louis |
PLCO |
Mar 20, 2008 |
2008-0008 |
| Prostate dataset evaluation |
Timothy Wong |
Independent |
PLCO |
Oct 5, 2017 |
PLCO-316 |
| Prostate Specific Antigen (PSA) Growth Curves: an Innovation to Improve Prostate Cancer Screening |
James Hebert |
University of South Carolina, Cancer Prevention and Control Program |
PLCO |
Feb 22, 2013 |
PLCO-15 |
| Prostate specific antigen volatility and the diagnosis of clinically significant prostate cancer |
John Leppert |
Stanford University |
PLCO |
Aug 29, 2022 |
PLCO-1034 |
| Proteomic Analyses of Serial Prediagnostic PLCO Plasma in Cases and Controls to Identify Early Detection Ovarian Cancer Biomarkers Rising in a Substantial Fraction of Cases and Stable in Most Controls |
Steven Skates |
Massachusetts General Hospital |
PLCO |
Sep 23, 2021 |
2020-1013 |
| Proteomic, Glycomic and Autoantibody Lung Cancer Biomarker Validation |
PAUL D Lampe |
FRED HUTCHINSON CANCER RES CTR |
PLCO |
|
2014-0170 |
| Proteomic, Glycomic and Autoantibody Markers that Complement CT Imaging for Early Lung Cancer Detection |
Paul Kinahan |
University of Washington |
NLST |
Jul 29, 2016 |
NLST-220 |
| Prototype System for Supporting Urologists in Bladder Tumor Detection |
Jaime Hugo Puebla Lomas |
Instituto Politécnico Nacional |
PLCO |
Apr 18, 2024 |
PLCOI-1527 |
| Provide patients with an improved cancer screening recommendation |
Sebastian Roth |
Ludwig-Maximilians-Universität Munich - Chair for Mobile and Distributed Systems |
PLCO |
Jun 21, 2021 |
PLCO-798 |
| PSA and CA125 in relation to epidemiologic, serologic, and genetic data and cancer risk in PLCO |
Michael Cook |
NCI |
PLCO |
Aug 23, 2018 |
PLCO-394 |
| PSA changes and prostate cancer characteristics and mortality |
Jonathan Shoag |
University Hospitals |
PLCO |
Jun 25, 2025 |
PLCO-1930 |
